Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14676 - 14700 of 14815 in total
Investigational
Lurtotecan is under investigation in clinical trial NCT00022594 (Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer).
Investigational
Matched Iupac: … ^{3,12}.0^{5,10}.0^{15,24}.0^{17,22}]pentacosa-1(14),2,4,10,12,15,17(22)-heptaene-19,23-dione ... (18S)-18-ethyl-18-hydroxy-2-[(4-methylpiperazin-1-yl)methyl]-6,9,20-trioxa-13,24-diazahexacyclo[12.11.0.0 …
Matched Description: … Lurtotecan is under investigation in clinical trial NCT00022594 (Liposomal Lurtotecan in Treating Patients …
Nolatrexed is under investigation in clinical trial NCT00012324 (Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer).
Investigational
Matched Description: … With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer). ... Nolatrexed is under investigation in clinical trial NCT00012324 (Nolatrexed Dihydrochloride Compared …
Rogaratinib is under investigation in clinical trial NCT03762122 (Rogaratinib in Patients With Advanced Pretreated Squamous-cell Non-small Cell Lung Cancer (SQCLC)).
Investigational
Matched Iupac: … 4-{[4-amino-5-(7-methoxy-5-methyl-1-benzothiophen-2-yl)-6-(methoxymethyl)pyrrolo[2,1-f][1,2,4]triazin …
Matched Description: … Rogaratinib is under investigation in clinical trial NCT03762122 (Rogaratinib in Patients With Advanced …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Investigational
Investigational
Isopentane is under investigation in clinical trial NCT00752089 (Experimental Dentifrice Remineralization/fluoride Uptake in an in Situ Model).
Investigational
Matched Description: … /fluoride Uptake in an in Situ Model). ... Isopentane is under investigation in clinical trial NCT00752089 (Experimental Dentifrice Remineralization …
Sulopenem etzadroxil is under investigation in clinical trial NCT03354598 (Oral Sulopenem-etzadroxil/probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women).
Investigational
Matched Iupac: … 1-azabicyclo[3.2.0]hept-2-en-3-yl]sulfanyl}thiolan-1-ium-1-olate ... (1R,3S)-3-{[(5R,6S)-2-({[(2-ethylbutanoyl)oxy]methoxy}carbonyl)-6-[(1R)-1-hydroxyethyl]-7-oxo-4-thia- …
Matched Description: … probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women). ... Sulopenem etzadroxil is under investigation in clinical trial NCT03354598 (Oral Sulopenem-etzadroxil/ …
Investigational
Matched Iupac: … N-(3-aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxo-4H-chromen-2-yl)-2-methylpropyl]-4-methylbenzamide …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Investigational
Matched Iupac: … 1-[2-(naphthalen-2-yl)ethyl]-4-[3-(trifluoromethyl)phenyl]-1,2,3,6-tetrahydropyridine …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Investigational
Matched Iupac: … {[(2R)-3,4-dihydro-2H-1-benzopyran-2-yl]methyl}({[5-(4-fluorophenyl)pyridin-3-yl]methyl})amine …
Investigational
Investigational
Matched Iupac: … 4-{[2-(2,4-dinitrophenyl)hydrazin-1-ylidene](4-hydroxyphenyl)methyl}phenol …
Investigational
Investigational
Investigational
Matched Iupac: … (1R,2S,3R)-1-{2-[(1E)-1-(hydroxyimino)ethyl]-1H-imidazol-5-yl}butane-1,2,3,4-tetrol …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Investigational
Disaccharide tripeptide glycerol dipalmitoyl is under investigation in clinical trial NCT00003667 (Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma).
Investigational
Matched Iupac: … (2R)-1-{[(2S)-2-[(4R)-4-carbamoyl-4-[(2S)-2-[(2R)-2-{[(2R,3R,4R,5R)-2-acetamido-4-{[(2S,3R,4R,5S,6R)- ... 3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydroxy-1-oxohexan-3-yl]oxy}propanamido …
Matched Description: … Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma). ... Disaccharide tripeptide glycerol dipalmitoyl is under investigation in clinical trial NCT00003667 (Combination …
ISP-001 consists of sleeping beauty transposon-engineered autologous plasmablasts for expression and delivery of alpha-L-iduronidase.
Investigational
Matched Description: … delivery of alpha-L-iduronidase. ... ISP-001 consists of sleeping beauty transposon-engineered autologous plasmablasts for expression and …
Exicorilant is under investigation in clinical trial NCT03437941 (Study to Evaluate CORT125281 in Combination With Enzalutamide in Patients With Mcrpc).
Investigational
Matched Iupac: … 2-[(4aR,8aS)-1-(4-fluorophenyl)-6-[(2-methyl-2H-1,2,3-triazol-4-yl)sulfonyl]-1H,4H,4aH,5H,6H,7H,8H,8aH …
Matched Description: … Exicorilant is under investigation in clinical trial NCT03437941 (Study to Evaluate CORT125281 in Combination ... With Enzalutamide in Patients With Mcrpc). …
Ilaprazole has been investigated in Helicobacter Infections.
Investigational
Matched Iupac: … 2-[(4-methoxy-3-methylpyridin-2-yl)methanesulfinyl]-5-(1H-pyrrol-1-yl)-1H-1,3-benzodiazole …
Matched Description: … Ilaprazole has been investigated in Helicobacter Infections. …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Iguratimod is under investigation in Rheumatoid Arthritis.
Investigational
Matched Description: … Iguratimod is under investigation in Rheumatoid Arthritis. …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Bucindolol has been investigated in Heart Failure.
Investigational
Matched Iupac: … 2-(2-hydroxy-3-{[1-(1H-indol-3-yl)-2-methylpropan-2-yl]amino}propoxy)benzonitrile …
Matched Description: … Bucindolol has been investigated in Heart Failure. …
Matched Categories: … Adrenergic alpha-1 Receptor Antagonists …
Cabiralizumab is under investigation in clinical trial NCT03502330 (APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma).
Investigational
Matched Description: … in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma). ... Cabiralizumab is under investigation in clinical trial NCT03502330 (APX005M With Nivolumab and Cabiralizumab …
Ningetinib is under investigation in clinical trial NCT03758287 (Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative).
Investigational
Matched Description: … in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative). ... Ningetinib is under investigation in clinical trial NCT03758287 (Ningetinib (CT053PTSA) Plus Gefitinib …
Displaying drugs 14676 - 14700 of 14815 in total